

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | low-density lipoprotein particle clearance (GO:0034383) | 7.13314572 |
| 2 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 5.96728628 |
| 3 | regulation of cholesterol storage (GO:0010885) | 5.51527498 |
| 4 | vascular endothelial growth factor signaling pathway (GO:0038084) | 4.70626535 |
| 5 | substrate-dependent cell migration (GO:0006929) | 4.54821276 |
| 6 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 4.47323295 |
| 7 | regulation of sequestering of triglyceride (GO:0010889) | 4.45240422 |
| 8 | endodermal cell differentiation (GO:0035987) | 4.42674541 |
| 9 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.40128753 |
| 10 | white fat cell differentiation (GO:0050872) | 4.11924773 |
| 11 | brown fat cell differentiation (GO:0050873) | 4.11598685 |
| 12 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 4.11136747 |
| 13 | barbed-end actin filament capping (GO:0051016) | 4.06849172 |
| 14 | positive regulation of macrophage cytokine production (GO:0060907) | 4.03776801 |
| 15 | cell adhesion mediated by integrin (GO:0033627) | 4.03299443 |
| 16 | apoptotic cell clearance (GO:0043277) | 3.97246620 |
| 17 | cell migration involved in heart development (GO:0060973) | 3.94420458 |
| 18 | valine metabolic process (GO:0006573) | 3.92515540 |
| 19 | triglyceride catabolic process (GO:0019433) | 3.92345278 |
| 20 | lymph vessel development (GO:0001945) | 3.87517974 |
| 21 | basement membrane organization (GO:0071711) | 3.85816651 |
| 22 | phagocytosis, recognition (GO:0006910) | 3.83255140 |
| 23 | extracellular fibril organization (GO:0043206) | 3.82527898 |
| 24 | fatty acid transmembrane transport (GO:1902001) | 3.82277302 |
| 25 | glomerular filtration (GO:0003094) | 3.81076633 |
| 26 | growth hormone receptor signaling pathway (GO:0060396) | 3.79695220 |
| 27 | blood vessel maturation (GO:0001955) | 3.73711469 |
| 28 | COPI coating of Golgi vesicle (GO:0048205) | 3.73252985 |
| 29 | Golgi transport vesicle coating (GO:0048200) | 3.73252985 |
| 30 | type B pancreatic cell proliferation (GO:0044342) | 3.69945806 |
| 31 | protein heterotrimerization (GO:0070208) | 3.67111311 |
| 32 | * membrane raft organization (GO:0031579) | 3.66717149 |
| 33 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 3.66528939 |
| 34 | negative regulation of chondrocyte differentiation (GO:0032331) | 3.65729810 |
| 35 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.65426604 |
| 36 | actin filament depolymerization (GO:0030042) | 3.62313038 |
| 37 | muscle cell migration (GO:0014812) | 3.61560070 |
| 38 | lymphangiogenesis (GO:0001946) | 3.61161426 |
| 39 | renal filtration (GO:0097205) | 3.59041949 |
| 40 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.58140150 |
| 41 | kidney mesenchyme development (GO:0072074) | 3.49905658 |
| 42 | negative regulation of lipid storage (GO:0010888) | 3.49041317 |
| 43 | mesenchymal-epithelial cell signaling (GO:0060638) | 3.48377336 |
| 44 | sprouting angiogenesis (GO:0002040) | 3.47625218 |
| 45 | protein retention in ER lumen (GO:0006621) | 3.46676828 |
| 46 | skin morphogenesis (GO:0043589) | 3.46521531 |
| 47 | wound healing, spreading of epidermal cells (GO:0035313) | 3.46099335 |
| 48 | ovulation from ovarian follicle (GO:0001542) | 3.45538320 |
| 49 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.43363938 |
| 50 | acylglycerol catabolic process (GO:0046464) | 3.42867349 |
| 51 | neutral lipid catabolic process (GO:0046461) | 3.42867349 |
| 52 | extracellular matrix assembly (GO:0085029) | 3.39329083 |
| 53 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.39156762 |
| 54 | axon extension involved in axon guidance (GO:0048846) | 3.39156762 |
| 55 | desmosome organization (GO:0002934) | 3.34581310 |
| 56 | regulation of vasculogenesis (GO:2001212) | 3.31642535 |
| 57 | endothelium development (GO:0003158) | 3.31226000 |
| 58 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.29672536 |
| 59 | fibril organization (GO:0097435) | 3.28929934 |
| 60 | regulation of plasminogen activation (GO:0010755) | 3.27295166 |
| 61 | positive regulation of smooth muscle cell migration (GO:0014911) | 3.27134169 |
| 62 | cellular response to growth hormone stimulus (GO:0071378) | 3.26046111 |
| 63 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 3.25832455 |
| 64 | endothelial cell morphogenesis (GO:0001886) | 3.22307294 |
| 65 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.22044400 |
| 66 | endocardial cushion development (GO:0003197) | 3.20884793 |
| 67 | positive regulation of vasculogenesis (GO:2001214) | 3.19546407 |
| 68 | substrate adhesion-dependent cell spreading (GO:0034446) | 3.18612685 |
| 69 | regulation of tight junction assembly (GO:2000810) | 3.18223101 |
| 70 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.18003636 |
| 71 | metanephric mesenchyme development (GO:0072075) | 3.15894964 |
| 72 | stress fiber assembly (GO:0043149) | 3.14526892 |
| 73 | lipid particle organization (GO:0034389) | 3.13700734 |
| 74 | endothelial cell proliferation (GO:0001935) | 3.13608041 |
| 75 | negative regulation of fatty acid transport (GO:2000192) | 3.13244320 |
| 76 | protein localization to cell surface (GO:0034394) | 3.12581402 |
| 77 | focal adhesion assembly (GO:0048041) | 3.12091597 |
| 78 | cell-substrate adherens junction assembly (GO:0007045) | 3.12091597 |
| 79 | negative regulation of smooth muscle cell migration (GO:0014912) | 3.11930085 |
| 80 | response to gravity (GO:0009629) | 3.11501514 |
| 81 | protein hydroxylation (GO:0018126) | 3.09816783 |
| 82 | wound healing, spreading of cells (GO:0044319) | 3.09411396 |
| 83 | regulation of endothelial cell differentiation (GO:0045601) | 3.07963789 |
| 84 | regulation of macrophage cytokine production (GO:0010935) | 3.07269599 |
| 85 | positive regulation of lipid storage (GO:0010884) | 3.04335351 |
| 86 | surfactant homeostasis (GO:0043129) | 3.04295546 |
| 87 | heart trabecula formation (GO:0060347) | 3.04069379 |
| 88 | positive regulation of endothelial cell migration (GO:0010595) | 3.03776877 |
| 89 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.03075525 |
| 90 | adherens junction assembly (GO:0034333) | 3.03014439 |
| 91 | peptidyl-proline hydroxylation (GO:0019511) | 3.02525073 |
| 92 | cellular response to vitamin D (GO:0071305) | 3.02036917 |
| 93 | protein maturation by protein folding (GO:0022417) | 3.01420468 |
| 94 | hypotonic response (GO:0006971) | 3.01216461 |
| 95 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.00511382 |
| 96 | * negative regulation of endothelial cell proliferation (GO:0001937) | 2.96878628 |
| 97 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.91023866 |
| 98 | positive regulation of fatty acid oxidation (GO:0046321) | 2.90895872 |
| 99 | collagen metabolic process (GO:0032963) | 2.87961338 |
| 100 | regulation of lipid storage (GO:0010883) | 2.87747213 |
| 101 | negative regulation of cartilage development (GO:0061037) | 2.87722608 |
| 102 | regulation of epithelial cell differentiation involved in kidney development (GO:2000696) | 2.86968264 |
| 103 | positive regulation of cholesterol efflux (GO:0010875) | 2.86003164 |
| 104 | collagen fibril organization (GO:0030199) | 2.85545996 |
| 105 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.82458364 |
| 106 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.80868809 |
| 107 | positive regulation of glomerulus development (GO:0090193) | 2.79696185 |
| 108 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.79096956 |
| 109 | positive regulation of epithelial cell migration (GO:0010634) | 2.79072416 |
| 110 | negative regulation of stem cell proliferation (GO:2000647) | 2.78402608 |
| 111 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.77179320 |
| 112 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.76652048 |
| 113 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.75534309 |
| 114 | extracellular matrix disassembly (GO:0022617) | 2.75305501 |
| 115 | positive regulation of actin filament depolymerization (GO:0030836) | 2.73703386 |
| 116 | hippo signaling (GO:0035329) | 2.73638686 |
| 117 | endothelial tube morphogenesis (GO:0061154) | 2.73600985 |
| 118 | morphogenesis of an endothelium (GO:0003159) | 2.73600985 |
| 119 | fibroblast migration (GO:0010761) | 2.73092419 |
| 120 | cardiac muscle cell proliferation (GO:0060038) | 2.71616147 |
| 121 | hemidesmosome assembly (GO:0031581) | 2.70870146 |
| 122 | extracellular matrix organization (GO:0030198) | 2.70738778 |
| 123 | extracellular structure organization (GO:0043062) | 2.69675409 |
| 124 | blood vessel endothelial cell migration (GO:0043534) | 2.67809632 |
| 125 | positive regulation of fibroblast migration (GO:0010763) | 2.67748140 |
| 126 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.67401452 |
| 127 | positive regulation of sterol transport (GO:0032373) | 2.67077269 |
| 128 | positive regulation of cholesterol transport (GO:0032376) | 2.67077269 |
| 129 | cGMP-mediated signaling (GO:0019934) | 2.66441801 |
| 130 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.65747312 |
| 131 | endothelial cell chemotaxis (GO:0035767) | 2.65732194 |
| 132 | cell-substrate junction assembly (GO:0007044) | 2.64098186 |
| 133 | positive regulation of osteoblast proliferation (GO:0033690) | 2.63730517 |
| 134 | mesodermal cell differentiation (GO:0048333) | 2.63675772 |
| 135 | * lipid storage (GO:0019915) | 2.62033914 |
| 136 | transcytosis (GO:0045056) | 2.61868433 |
| 137 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.61785176 |
| 138 | protein localization to endosome (GO:0036010) | 2.61528803 |
| 139 | protein targeting to plasma membrane (GO:0072661) | 2.61358099 |
| 140 | plasma lipoprotein particle clearance (GO:0034381) | 2.60703806 |
| 141 | regulation of smooth muscle cell migration (GO:0014910) | 2.59129586 |
| 142 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.58818199 |
| 143 | collagen catabolic process (GO:0030574) | 2.58229111 |
| 144 | positive regulation of receptor recycling (GO:0001921) | 2.57668304 |
| 145 | negative regulation of protein autophosphorylation (GO:0031953) | 2.54759452 |
| 146 | plasma membrane repair (GO:0001778) | 2.54496493 |
| 147 | hyaluronan catabolic process (GO:0030214) | 2.54162992 |
| 148 | heparan sulfate proteoglycan biosynthetic process (GO:0015012) | 2.54027734 |
| 149 | multicellular organismal metabolic process (GO:0044236) | 2.53828191 |
| 150 | chondrocyte proliferation (GO:0035988) | 2.53774464 |
| 151 | smooth muscle tissue development (GO:0048745) | 2.53094414 |
| 152 | biotin metabolic process (GO:0006768) | 2.51955081 |
| 153 | positive regulation of cartilage development (GO:0061036) | 2.51659939 |
| 154 | regulation of glomerular filtration (GO:0003093) | 2.51208936 |
| 155 | cortical actin cytoskeleton organization (GO:0030866) | 2.51018573 |
| 156 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 2.50663240 |
| 157 | adhesion of symbiont to host (GO:0044406) | 2.50375937 |
| 158 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.50240644 |
| 159 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.48754163 |
| 160 | ventricular cardiac muscle cell development (GO:0055015) | 2.48634146 |
| 161 | carnitine shuttle (GO:0006853) | 2.47194694 |
| 162 | cellular response to vitamin (GO:0071295) | 2.46704419 |
| 163 | blood vessel remodeling (GO:0001974) | 2.45410263 |
| 164 | negative regulation of cell junction assembly (GO:1901889) | 2.45361377 |
| 165 | negative regulation of adherens junction organization (GO:1903392) | 2.45361377 |
| 166 | cellular response to lithium ion (GO:0071285) | 2.44814718 |
| 167 | epithelial cell-cell adhesion (GO:0090136) | 2.44582568 |
| 168 | * membrane assembly (GO:0071709) | 2.44276167 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.58793397 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 5.54649477 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.07686374 |
| 4 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.66369832 |
| 5 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.56630111 |
| 6 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.42360039 |
| 7 | GATA1_22025678_ChIP-Seq_K562_Human | 2.73724267 |
| 8 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.57660039 |
| 9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.46983953 |
| 10 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.31450020 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.27811650 |
| 12 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.25463294 |
| 13 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.21548843 |
| 14 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.21292735 |
| 15 | * CJUN_26792858_Chip-Seq_BT549_Human | 2.16498811 |
| 16 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.15413549 |
| 17 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.10151302 |
| 18 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.05732557 |
| 19 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 2.04827469 |
| 20 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.04023525 |
| 21 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.94812881 |
| 22 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.85576260 |
| 23 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.80757937 |
| 24 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.80362380 |
| 25 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.73782095 |
| 26 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.71400395 |
| 27 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.71400395 |
| 28 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.70463445 |
| 29 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.69181648 |
| 30 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.64221172 |
| 31 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.63047354 |
| 32 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.62567230 |
| 33 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.62025696 |
| 34 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.62025696 |
| 35 | * CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.61684145 |
| 36 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.58372702 |
| 37 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.58340281 |
| 38 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.57251632 |
| 39 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.54296415 |
| 40 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.53281296 |
| 41 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.52040225 |
| 42 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.51865915 |
| 43 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.51865915 |
| 44 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.51505738 |
| 45 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.51263581 |
| 46 | * MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.51015817 |
| 47 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.45523931 |
| 48 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.45024823 |
| 49 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.44964262 |
| 50 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.43532359 |
| 51 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.43201533 |
| 52 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.42119461 |
| 53 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.40762139 |
| 54 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.39628904 |
| 55 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.38896251 |
| 56 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.37733549 |
| 57 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.37599528 |
| 58 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.37433046 |
| 59 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.36524254 |
| 60 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.34565159 |
| 61 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.34551237 |
| 62 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.32769026 |
| 63 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.32492529 |
| 64 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.32335924 |
| 65 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.32270085 |
| 66 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.32115412 |
| 67 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.31547116 |
| 68 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.30995400 |
| 69 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.30292778 |
| 70 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.29089297 |
| 71 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.28593237 |
| 72 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.26862606 |
| 73 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.25960421 |
| 74 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.25039745 |
| 75 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.23964632 |
| 76 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.20678376 |
| 77 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.20343172 |
| 78 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.19036702 |
| 79 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.17732824 |
| 80 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.17252755 |
| 81 | TP53_16413492_ChIP-PET_HCT116_Human | 1.15787168 |
| 82 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.15682220 |
| 83 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.11712807 |
| 84 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.11365928 |
| 85 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11051857 |
| 86 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.09613315 |
| 87 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09601260 |
| 88 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.09497498 |
| 89 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08409486 |
| 90 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.06888602 |
| 91 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.06876400 |
| 92 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.05918149 |
| 93 | * SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.04879202 |
| 94 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.02688828 |
| 95 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.02586634 |
| 96 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.02121643 |
| 97 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.00788256 |
| 98 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.00226865 |
| 99 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.99205166 |
| 100 | * RXR_22108803_ChIP-Seq_LS180_Human | 0.99042795 |
| 101 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.99027419 |
| 102 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.98852427 |
| 103 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.96559945 |
| 104 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.95201865 |
| 105 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.94884557 |
| 106 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.94530205 |
| 107 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.93776860 |
| 108 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.93290037 |
| 109 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.92311888 |
| 110 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.92059625 |
| 111 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.91461145 |
| 112 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.88582408 |
| 113 | NFI_21473784_ChIP-Seq_ESCs_Mouse | 0.88320191 |
| 114 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.88078194 |
| 115 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.88068127 |
| 116 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.88010954 |
| 117 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.87771325 |
| 118 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.85102984 |
| 119 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.84401730 |
| 120 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.84033644 |
| 121 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.82907014 |
| 122 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.82848347 |
| 123 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.82314984 |
| 124 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.82230190 |
| 125 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.81633691 |
| 126 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.81486425 |
| 127 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.81445188 |
| 128 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.81279665 |
| 129 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.80749932 |
| 130 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.80603304 |
| 131 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.80388575 |
| 132 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.80297152 |
| 133 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79087589 |
| 134 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78672845 |
| 135 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.78582532 |
| 136 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.78582532 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 5.26440606 |
| 2 | MP0005670_abnormal_white_adipose | 4.20247217 |
| 3 | MP0004272_abnormal_basement_membrane | 3.90722239 |
| 4 | MP0001879_abnormal_lymphatic_vessel | 3.89370306 |
| 5 | MP0010368_abnormal_lymphatic_system | 3.76698615 |
| 6 | MP0005275_abnormal_skin_tensile | 3.51039194 |
| 7 | MP0004130_abnormal_muscle_cell | 3.13343682 |
| 8 | MP0003724_increased_susceptibility_to | 2.82750869 |
| 9 | MP0005257_abnormal_intraocular_pressure | 2.75516022 |
| 10 | MP0005666_abnormal_adipose_tissue | 2.73813308 |
| 11 | MP0000013_abnormal_adipose_tissue | 2.64547471 |
| 12 | MP0003279_aneurysm | 2.49076025 |
| 13 | MP0004185_abnormal_adipocyte_glucose | 2.34081670 |
| 14 | * MP0003705_abnormal_hypodermis_morpholog | 2.27072927 |
| 15 | MP0001958_emphysema | 2.25169888 |
| 16 | MP0005167_abnormal_blood-brain_barrier | 2.24960627 |
| 17 | * MP0003828_pulmonary_edema | 2.24830004 |
| 18 | MP0005375_adipose_tissue_phenotype | 2.23197954 |
| 19 | MP0010352_gastrointestinal_tract_polyps | 2.19049930 |
| 20 | * MP0002332_abnormal_exercise_endurance | 2.17454796 |
| 21 | MP0003566_abnormal_cell_adhesion | 2.16459357 |
| 22 | * MP0003191_abnormal_cellular_cholesterol | 2.15982602 |
| 23 | MP0010030_abnormal_orbit_morphology | 2.10616501 |
| 24 | MP0003941_abnormal_skin_development | 1.97945168 |
| 25 | MP0000343_altered_response_to | 1.88426707 |
| 26 | MP0000003_abnormal_adipose_tissue | 1.87242694 |
| 27 | MP0000767_abnormal_smooth_muscle | 1.85270136 |
| 28 | MP0002837_dystrophic_cardiac_calcinosis | 1.79842126 |
| 29 | MP0000762_abnormal_tongue_morphology | 1.78523893 |
| 30 | MP0000750_abnormal_muscle_regeneration | 1.75562430 |
| 31 | * MP0006138_congestive_heart_failure | 1.66699240 |
| 32 | * MP0001542_abnormal_bone_strength | 1.65853712 |
| 33 | MP0001299_abnormal_eye_distance/ | 1.62937697 |
| 34 | MP0002295_abnormal_pulmonary_circulatio | 1.56319606 |
| 35 | MP0004147_increased_porphyrin_level | 1.55930909 |
| 36 | MP0009053_abnormal_anal_canal | 1.52838110 |
| 37 | MP0002108_abnormal_muscle_morphology | 1.50925680 |
| 38 | MP0004084_abnormal_cardiac_muscle | 1.49462252 |
| 39 | * MP0001544_abnormal_cardiovascular_syste | 1.48892489 |
| 40 | * MP0005385_cardiovascular_system_phenoty | 1.48892489 |
| 41 | * MP0003091_abnormal_cell_migration | 1.44982027 |
| 42 | * MP0003950_abnormal_plasma_membrane | 1.44039746 |
| 43 | MP0009278_abnormal_bone_marrow | 1.43663352 |
| 44 | MP0008775_abnormal_heart_ventricle | 1.42769823 |
| 45 | MP0005171_absent_coat_pigmentation | 1.41910715 |
| 46 | MP0001243_abnormal_dermal_layer | 1.37416501 |
| 47 | MP0004215_abnormal_myocardial_fiber | 1.37236271 |
| 48 | MP0006054_spinal_hemorrhage | 1.37093121 |
| 49 | MP0005503_abnormal_tendon_morphology | 1.31971670 |
| 50 | * MP0009115_abnormal_fat_cell | 1.27510040 |
| 51 | * MP0002971_abnormal_brown_adipose | 1.26282983 |
| 52 | * MP0005164_abnormal_response_to | 1.25881011 |
| 53 | MP0004782_abnormal_surfactant_physiolog | 1.25642896 |
| 54 | * MP0002896_abnormal_bone_mineralization | 1.23513198 |
| 55 | MP0005623_abnormal_meninges_morphology | 1.23206695 |
| 56 | * MP0005620_abnormal_muscle_contractility | 1.18821498 |
| 57 | MP0001849_ear_inflammation | 1.18649746 |
| 58 | MP0001348_abnormal_lacrimal_gland | 1.18077509 |
| 59 | MP0002060_abnormal_skin_morphology | 1.15218587 |
| 60 | * MP0000249_abnormal_blood_vessel | 1.15011476 |
| 61 | * MP0004087_abnormal_muscle_fiber | 1.14536599 |
| 62 | * MP0002972_abnormal_cardiac_muscle | 1.13954595 |
| 63 | MP0000534_abnormal_ureter_morphology | 1.12959566 |
| 64 | MP0002877_abnormal_melanocyte_morpholog | 1.12611647 |
| 65 | MP0009250_abnormal_appendicular_skeleto | 1.12454716 |
| 66 | MP0003448_altered_tumor_morphology | 1.11391540 |
| 67 | * MP0002133_abnormal_respiratory_system | 1.10595108 |
| 68 | * MP0005388_respiratory_system_phenotype | 1.10595108 |
| 69 | MP0004233_abnormal_muscle_weight | 1.10460618 |
| 70 | MP0000467_abnormal_esophagus_morphology | 1.07951678 |
| 71 | MP0003385_abnormal_body_wall | 1.07027375 |
| 72 | * MP0005595_abnormal_vascular_smooth | 1.07018052 |
| 73 | MP0001545_abnormal_hematopoietic_system | 1.06926839 |
| 74 | MP0005397_hematopoietic_system_phenotyp | 1.06926839 |
| 75 | * MP0001533_abnormal_skeleton_physiology | 1.03898679 |
| 76 | MP0010329_abnormal_lipoprotein_level | 1.02922805 |
| 77 | MP0003567_abnormal_fetal_cardiomyocyte | 1.00893309 |
| 78 | MP0000751_myopathy | 1.00509552 |
| 79 | * MP0001614_abnormal_blood_vessel | 0.98149489 |
| 80 | * MP0005023_abnormal_wound_healing | 0.98103728 |
| 81 | MP0000733_abnormal_muscle_development | 0.97394191 |
| 82 | MP0002166_altered_tumor_susceptibility | 0.96292913 |
| 83 | MP0009764_decreased_sensitivity_to | 0.95403763 |
| 84 | MP0003300_gastrointestinal_ulcer | 0.95352842 |
| 85 | MP0005197_abnormal_uvea_morphology | 0.95115695 |
| 86 | MP0003221_abnormal_cardiomyocyte_apopto | 0.93995985 |
| 87 | MP0002234_abnormal_pharynx_morphology | 0.93908724 |
| 88 | MP0002128_abnormal_blood_circulation | 0.92939632 |
| 89 | * MP0010630_abnormal_cardiac_muscle | 0.92763477 |
| 90 | MP0005409_darkened_coat_color | 0.90381687 |
| 91 | MP0004036_abnormal_muscle_relaxation | 0.89980795 |
| 92 | * MP0005334_abnormal_fat_pad | 0.89695125 |
| 93 | MP0000858_altered_metastatic_potential | 0.89670387 |
| 94 | * MP0005330_cardiomyopathy | 0.89166608 |
| 95 | MP0003690_abnormal_glial_cell | 0.87961501 |
| 96 | MP0001177_atelectasis | 0.86162857 |
| 97 | * MP0005165_increased_susceptibility_to | 0.85575247 |
| 98 | MP0004858_abnormal_nervous_system | 0.85007144 |
| 99 | * MP0003045_fibrosis | 0.84794623 |
| 100 | MP0002925_abnormal_cardiovascular_devel | 0.82019478 |
| 101 | MP0000747_muscle_weakness | 0.81251914 |
| 102 | MP0002006_tumorigenesis | 0.80489615 |
| 103 | * MP0000759_abnormal_skeletal_muscle | 0.79727198 |
| 104 | MP0005193_abnormal_anterior_eye | 0.79681817 |
| 105 | MP0004484_altered_response_of | 0.78526331 |
| 106 | * MP0000163_abnormal_cartilage_morphology | 0.78461163 |
| 107 | MP0009384_cardiac_valve_regurgitation | 0.78239011 |
| 108 | MP0005501_abnormal_skin_physiology | 0.78132412 |
| 109 | MP0003453_abnormal_keratinocyte_physiol | 0.77456693 |
| 110 | MP0002998_abnormal_bone_remodeling | 0.77068044 |
| 111 | MP0003755_abnormal_palate_morphology | 0.75176132 |
| 112 | MP0003942_abnormal_urinary_system | 0.75168597 |
| 113 | MP0002269_muscular_atrophy | 0.74873766 |
| 114 | MP0003959_abnormal_lean_body | 0.74251752 |
| 115 | MP0002796_impaired_skin_barrier | 0.74217223 |
| 116 | MP0010771_integument_phenotype | 0.74026501 |
| 117 | MP0003186_abnormal_redox_activity | 0.73308881 |
| 118 | MP0005508_abnormal_skeleton_morphology | 0.72483764 |
| 119 | MP0000749_muscle_degeneration | 0.71736412 |
| 120 | * MP0002970_abnormal_white_adipose | 0.71186532 |
| 121 | * MP0002118_abnormal_lipid_homeostasis | 0.70389672 |
| 122 | MP0002138_abnormal_hepatobiliary_system | 0.69771964 |
| 123 | * MP0005390_skeleton_phenotype | 0.69559316 |
| 124 | MP0002177_abnormal_outer_ear | 0.68874399 |
| 125 | MP0002106_abnormal_muscle_physiology | 0.68465340 |
| 126 | MP0002933_joint_inflammation | 0.68186299 |
| 127 | * MP0002113_abnormal_skeleton_development | 0.67366951 |
| 128 | * MP0000230_abnormal_systemic_arterial | 0.66710613 |
| 129 | * MP0002168_other_aberrant_phenotype | 0.66703576 |
| 130 | * MP0001881_abnormal_mammary_gland | 0.66299554 |
| 131 | MP0002932_abnormal_joint_morphology | 0.66224756 |
| 132 | * MP0001216_abnormal_epidermal_layer | 0.65510462 |
| 133 | MP0005369_muscle_phenotype | 0.65043371 |
| 134 | MP0001915_intracranial_hemorrhage | 0.64705172 |
| 135 | * MP0000266_abnormal_heart_morphology | 0.64145209 |
| 136 | MP0002876_abnormal_thyroid_physiology | 0.63919963 |
| 137 | MP0000428_abnormal_craniofacial_morphol | 0.63703355 |
| 138 | MP0001661_extended_life_span | 0.63574237 |
| 139 | MP0010386_abnormal_urinary_bladder | 0.61833079 |
| 140 | MP0010234_abnormal_vibrissa_follicle | 0.61723756 |
| 141 | MP0002282_abnormal_trachea_morphology | 0.61184495 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Premature rupture of membranes (HP:0001788) | 5.12071825 |
| 2 | Increased connective tissue (HP:0009025) | 4.85892629 |
| 3 | Cerebral aneurysm (HP:0004944) | 4.71410367 |
| 4 | Protrusio acetabuli (HP:0003179) | 4.54332131 |
| 5 | * Acanthosis nigricans (HP:0000956) | 4.14710632 |
| 6 | Spinal rigidity (HP:0003306) | 4.07722090 |
| 7 | Aortic dissection (HP:0002647) | 3.98457674 |
| 8 | Aortic aneurysm (HP:0004942) | 3.96973376 |
| 9 | Hematochezia (HP:0002573) | 3.82793207 |
| 10 | Broad metatarsal (HP:0001783) | 3.81168100 |
| 11 | Oligomenorrhea (HP:0000876) | 3.70796423 |
| 12 | Ankle contracture (HP:0006466) | 3.58786545 |
| 13 | Shallow orbits (HP:0000586) | 3.49168071 |
| 14 | Muscle fiber splitting (HP:0003555) | 3.46542830 |
| 15 | Atrophic scars (HP:0001075) | 3.45234155 |
| 16 | Type 1 muscle fiber predominance (HP:0003803) | 3.39227461 |
| 17 | Increased variability in muscle fiber diameter (HP:0003557) | 3.10394037 |
| 18 | Polycythemia (HP:0001901) | 3.05176903 |
| 19 | * Hypertriglyceridemia (HP:0002155) | 3.04859306 |
| 20 | Right ventricular cardiomyopathy (HP:0011663) | 3.04287254 |
| 21 | Difficulty running (HP:0009046) | 3.03899989 |
| 22 | Dilatation of the ascending aorta (HP:0005111) | 3.01682558 |
| 23 | Vertebral compression fractures (HP:0002953) | 3.00540785 |
| 24 | Peritonitis (HP:0002586) | 2.99118053 |
| 25 | Hyporeflexia of lower limbs (HP:0002600) | 2.97518670 |
| 26 | Follicular hyperkeratosis (HP:0007502) | 2.95427519 |
| 27 | Spondylolisthesis (HP:0003302) | 2.88496471 |
| 28 | Soft skin (HP:0000977) | 2.82087636 |
| 29 | Abnormality of dentin (HP:0010299) | 2.81434438 |
| 30 | Osteolytic defects of the hand bones (HP:0009699) | 2.79587468 |
| 31 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.79587468 |
| 32 | Aneurysm (HP:0002617) | 2.76816670 |
| 33 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.76406744 |
| 34 | Distal lower limb muscle weakness (HP:0009053) | 2.70134777 |
| 35 | Generalized amyotrophy (HP:0003700) | 2.62644856 |
| 36 | Neonatal short-limb short stature (HP:0008921) | 2.57072475 |
| 37 | Mitral valve prolapse (HP:0001634) | 2.56156675 |
| 38 | Myocardial infarction (HP:0001658) | 2.54317614 |
| 39 | Spontaneous hematomas (HP:0007420) | 2.54047526 |
| 40 | Fragile skin (HP:0001030) | 2.53677289 |
| 41 | Natal tooth (HP:0000695) | 2.52363064 |
| 42 | Cardiovascular calcification (HP:0011915) | 2.51665403 |
| 43 | Cerebral hemorrhage (HP:0001342) | 2.51655725 |
| 44 | Popliteal pterygium (HP:0009756) | 2.50340385 |
| 45 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.50098752 |
| 46 | * Lipoatrophy (HP:0100578) | 2.49819469 |
| 47 | Vascular tortuosity (HP:0004948) | 2.49496995 |
| 48 | Difficulty climbing stairs (HP:0003551) | 2.46776022 |
| 49 | Venous abnormality (HP:0002624) | 2.45902342 |
| 50 | Mitral regurgitation (HP:0001653) | 2.45115742 |
| 51 | Hemorrhage of the eye (HP:0011885) | 2.36517629 |
| 52 | Distal lower limb amyotrophy (HP:0008944) | 2.35407258 |
| 53 | Scapular winging (HP:0003691) | 2.34741122 |
| 54 | Genu recurvatum (HP:0002816) | 2.31599956 |
| 55 | Joint laxity (HP:0001388) | 2.30718917 |
| 56 | Tetraparesis (HP:0002273) | 2.27854240 |
| 57 | Aortic regurgitation (HP:0001659) | 2.27269550 |
| 58 | Pterygium (HP:0001059) | 2.26724282 |
| 59 | Bladder diverticulum (HP:0000015) | 2.26380430 |
| 60 | Facial diplegia (HP:0001349) | 2.26102912 |
| 61 | Aortic valve stenosis (HP:0001650) | 2.26031855 |
| 62 | Increased mean platelet volume (HP:0011877) | 2.25543094 |
| 63 | Amniotic constriction ring (HP:0009775) | 2.25141310 |
| 64 | Abnormality of placental membranes (HP:0011409) | 2.25141310 |
| 65 | Coronal craniosynostosis (HP:0004440) | 2.25061157 |
| 66 | Arterial tortuosity (HP:0005116) | 2.23063798 |
| 67 | Entropion (HP:0000621) | 2.20476673 |
| 68 | Hypoplasia of the iris (HP:0007676) | 2.20431209 |
| 69 | Lymphangioma (HP:0100764) | 2.20423017 |
| 70 | Pigmentary retinal degeneration (HP:0001146) | 2.18839541 |
| 71 | Myotonia (HP:0002486) | 2.18486358 |
| 72 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.16947279 |
| 73 | Nemaline bodies (HP:0003798) | 2.16286805 |
| 74 | Blue sclerae (HP:0000592) | 2.15936631 |
| 75 | Abnormal delivery (HP:0001787) | 2.13686892 |
| 76 | Round ear (HP:0100830) | 2.12883228 |
| 77 | Abnormality of the nasal mucosa (HP:0000433) | 2.12818301 |
| 78 | Abnormality of the acetabulum (HP:0003170) | 2.12654638 |
| 79 | * Reduced subcutaneous adipose tissue (HP:0003758) | 2.11260098 |
| 80 | Spinal cord lesions (HP:0100561) | 2.09014400 |
| 81 | Syringomyelia (HP:0003396) | 2.09014400 |
| 82 | Wormian bones (HP:0002645) | 2.08664154 |
| 83 | Mitral stenosis (HP:0001718) | 2.08353522 |
| 84 | Ventricular tachycardia (HP:0004756) | 2.07640559 |
| 85 | Esophageal varix (HP:0002040) | 2.06929338 |
| 86 | Abnormality of the umbilical cord (HP:0010881) | 2.06781551 |
| 87 | Cervical subluxation (HP:0003308) | 2.06534605 |
| 88 | Achilles tendon contracture (HP:0001771) | 2.05987133 |
| 89 | Sudden death (HP:0001699) | 2.05985770 |
| 90 | Ileus (HP:0002595) | 2.05754461 |
| 91 | Myoglobinuria (HP:0002913) | 2.05590966 |
| 92 | Ulnar bowing (HP:0003031) | 2.05041614 |
| 93 | Atrial fibrillation (HP:0005110) | 2.04266361 |
| 94 | Venous insufficiency (HP:0005293) | 2.03315286 |
| 95 | Long toe (HP:0010511) | 2.03056553 |
| 96 | Supraventricular arrhythmia (HP:0005115) | 2.01695918 |
| 97 | Hyperextensible skin (HP:0000974) | 2.00243569 |
| 98 | Wrist flexion contracture (HP:0001239) | 2.00079274 |
| 99 | Primary atrial arrhythmia (HP:0001692) | 1.98883185 |
| 100 | Abnormality of the anterior chamber (HP:0000593) | 1.98151154 |
| 101 | Toxemia of pregnancy (HP:0100603) | 1.96999736 |
| 102 | Bowel diverticulosis (HP:0005222) | 1.95470277 |
| 103 | Hypoalphalipoproteinemia (HP:0003233) | 1.94697912 |
| 104 | Onycholysis (HP:0001806) | 1.93490508 |
| 105 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.93026480 |
| 106 | Neck muscle weakness (HP:0000467) | 1.92862833 |
| 107 | Overgrowth (HP:0001548) | 1.92695811 |
| 108 | Abnormal platelet volume (HP:0011876) | 1.91852721 |
| 109 | Hydroxyprolinuria (HP:0003080) | 1.91271021 |
| 110 | Abnormality of proline metabolism (HP:0010907) | 1.91271021 |
| 111 | Lower limb amyotrophy (HP:0007210) | 1.90584306 |
| 112 | Limb-girdle muscle weakness (HP:0003325) | 1.90555979 |
| 113 | Delayed cranial suture closure (HP:0000270) | 1.90528306 |
| 114 | Pulmonary artery stenosis (HP:0004415) | 1.89803526 |
| 115 | Complement deficiency (HP:0004431) | 1.88999749 |
| 116 | Buphthalmos (HP:0000557) | 1.88748560 |
| 117 | Joint stiffness (HP:0001387) | 1.88630429 |
| 118 | Distal upper limb amyotrophy (HP:0007149) | 1.87794943 |
| 119 | Upper limb amyotrophy (HP:0009129) | 1.87794943 |
| 120 | Decreased subcutaneous fat (HP:0001002) | 1.87759058 |
| 121 | Biconcave vertebral bodies (HP:0004586) | 1.87128678 |
| 122 | Short nail (HP:0001799) | 1.86580923 |
| 123 | Muscle stiffness (HP:0003552) | 1.86486264 |
| 124 | Microglossia (HP:0000171) | 1.86314299 |
| 125 | Bronchomalacia (HP:0002780) | 1.86042791 |
| 126 | Visceral angiomatosis (HP:0100761) | 1.84984184 |
| 127 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.83731573 |
| 128 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.83640526 |
| 129 | Milia (HP:0001056) | 1.83336578 |
| 130 | * Bone cyst (HP:0012062) | 1.83284076 |
| 131 | Elbow flexion contracture (HP:0002987) | 1.82656462 |
| 132 | Slender build (HP:0001533) | 1.82654628 |
| 133 | Limb-girdle muscle atrophy (HP:0003797) | 1.82449230 |
| 134 | Interstitial pulmonary disease (HP:0006530) | 1.82156891 |
| 135 | Supraventricular tachycardia (HP:0004755) | 1.81782880 |
| 136 | Rectal prolapse (HP:0002035) | 1.81565419 |
| 137 | Delayed gross motor development (HP:0002194) | 1.81343661 |
| 138 | Neonatal death (HP:0003811) | 1.81079623 |
| 139 | Coxa vara (HP:0002812) | 1.80244054 |
| 140 | Breech presentation (HP:0001623) | 1.79908709 |
| 141 | Vascular calcification (HP:0004934) | 1.77747988 |
| 142 | Trismus (HP:0000211) | 1.76957521 |
| 143 | Protruding ear (HP:0000411) | 1.76236659 |
| 144 | Ectopia lentis (HP:0001083) | 1.76070300 |
| 145 | Knee flexion contracture (HP:0006380) | 1.75789572 |
| 146 | Eczematoid dermatitis (HP:0000976) | 1.75783881 |
| 147 | Spinal cord compression (HP:0002176) | 1.75604654 |
| 148 | Abnormal cartilage morphology (HP:0002763) | 1.75527643 |
| 149 | Wide anterior fontanel (HP:0000260) | 1.75466706 |
| 150 | Abnormality of the neuromuscular junction (HP:0003398) | 1.75425443 |
| 151 | Fatigable weakness (HP:0003473) | 1.75425443 |
| 152 | Muscular dystrophy (HP:0003560) | 1.75159516 |
| 153 | Abnormality of the Achilles tendon (HP:0005109) | 1.74585796 |
| 154 | Disproportionate tall stature (HP:0001519) | 1.73283339 |
| 155 | Mesomelia (HP:0003027) | 1.73198620 |
| 156 | Striae distensae (HP:0001065) | 1.71745867 |
| 157 | Bradycardia (HP:0001662) | 1.71395991 |
| 158 | Skin nodule (HP:0200036) | 1.71218123 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 5.92210163 |
| 2 | TRIB3 | 3.12283794 |
| 3 | TTN | 2.85380769 |
| 4 | EPHB2 | 2.69912975 |
| 5 | RIPK1 | 2.67067072 |
| 6 | EPHB1 | 2.50810701 |
| 7 | KDR | 2.48491404 |
| 8 | TGFBR2 | 2.45442424 |
| 9 | EPHA2 | 2.40556370 |
| 10 | NEK9 | 2.38383671 |
| 11 | CAMK1D | 2.21173651 |
| 12 | ERN1 | 2.10009132 |
| 13 | MYLK | 2.05377461 |
| 14 | MAP3K12 | 1.98129342 |
| 15 | MST4 | 1.98093823 |
| 16 | TGFBR1 | 1.94104663 |
| 17 | BCKDK | 1.89876150 |
| 18 | MUSK | 1.89778375 |
| 19 | FER | 1.88896665 |
| 20 | SIK1 | 1.83624451 |
| 21 | NTRK1 | 1.82167131 |
| 22 | EPHA3 | 1.82039086 |
| 23 | FGFR4 | 1.80680263 |
| 24 | FGFR3 | 1.76213386 |
| 25 | PDGFRA | 1.71618240 |
| 26 | MST1R | 1.68889717 |
| 27 | PTK2B | 1.66204855 |
| 28 | DDR2 | 1.57381991 |
| 29 | DMPK | 1.55674559 |
| 30 | PDK2 | 1.55451644 |
| 31 | LATS1 | 1.54539480 |
| 32 | ERBB4 | 1.50486632 |
| 33 | MAPKAPK3 | 1.50058380 |
| 34 | MAP3K3 | 1.47574809 |
| 35 | PTK6 | 1.46591959 |
| 36 | TRPM7 | 1.45555581 |
| 37 | IRAK3 | 1.37168800 |
| 38 | PDK4 | 1.33525744 |
| 39 | PDK3 | 1.33525744 |
| 40 | ARAF | 1.32122092 |
| 41 | LMTK2 | 1.28633094 |
| 42 | FLT3 | 1.28482540 |
| 43 | FRK | 1.26643727 |
| 44 | SCYL2 | 1.25096858 |
| 45 | LATS2 | 1.21449264 |
| 46 | NME2 | 1.18190419 |
| 47 | TAOK2 | 1.18011191 |
| 48 | CAMK1G | 1.16488633 |
| 49 | MAP2K3 | 1.15522411 |
| 50 | FGFR2 | 1.14753482 |
| 51 | PIK3CA | 1.11365952 |
| 52 | NEK1 | 1.10078725 |
| 53 | CDK8 | 1.06180151 |
| 54 | PKN2 | 1.05134332 |
| 55 | CSK | 1.04693461 |
| 56 | ERBB3 | 1.04374832 |
| 57 | ROCK2 | 1.01925078 |
| 58 | JAK1 | 1.00589066 |
| 59 | BMPR1B | 1.00118966 |
| 60 | PAK4 | 0.99685331 |
| 61 | MET | 0.98884268 |
| 62 | TESK1 | 0.97809143 |
| 63 | STK38 | 0.97268185 |
| 64 | BUB1 | 0.95760508 |
| 65 | PRKD2 | 0.94794848 |
| 66 | EIF2AK1 | 0.92981185 |
| 67 | PTK2 | 0.91862439 |
| 68 | PAK2 | 0.90671234 |
| 69 | PAK6 | 0.90304180 |
| 70 | LRRK2 | 0.87027711 |
| 71 | STK3 | 0.85707824 |
| 72 | PIM2 | 0.84533166 |
| 73 | ILK | 0.84253112 |
| 74 | TYK2 | 0.83943822 |
| 75 | PAK3 | 0.80243726 |
| 76 | MELK | 0.79029587 |
| 77 | ICK | 0.74612813 |
| 78 | TBK1 | 0.74075877 |
| 79 | PBK | 0.73951869 |
| 80 | CDK6 | 0.72439265 |
| 81 | MAP3K6 | 0.69579207 |
| 82 | MAP2K1 | 0.69208553 |
| 83 | BMX | 0.69049775 |
| 84 | MOS | 0.68189336 |
| 85 | PDGFRB | 0.66101194 |
| 86 | PRKD1 | 0.66060111 |
| 87 | FGFR1 | 0.65500414 |
| 88 | BCR | 0.65165117 |
| 89 | PRKAA2 | 0.64293041 |
| 90 | LIMK1 | 0.64278965 |
| 91 | PRKG2 | 0.64131896 |
| 92 | EIF2AK3 | 0.61856740 |
| 93 | DAPK3 | 0.61156330 |
| 94 | PAK1 | 0.60942622 |
| 95 | IGF1R | 0.60739713 |
| 96 | CDK9 | 0.60594103 |
| 97 | PIK3CG | 0.59121918 |
| 98 | GSK3A | 0.58899143 |
| 99 | ROCK1 | 0.58468435 |
| 100 | MARK3 | 0.58051095 |
| 101 | NUAK1 | 0.56403802 |
| 102 | RET | 0.54535781 |
| 103 | * INSR | 0.52969547 |
| 104 | ADRBK1 | 0.52907253 |
| 105 | CDC42BPA | 0.52515951 |
| 106 | JAK2 | 0.52439647 |
| 107 | PRKCH | 0.51600761 |
| 108 | OBSCN | 0.51306920 |
| 109 | JAK3 | 0.50639405 |
| 110 | ABL2 | 0.50597376 |
| 111 | SMG1 | 0.49681340 |
| 112 | PRKD3 | 0.48644445 |
| 113 | PHKG1 | 0.47774030 |
| 114 | PHKG2 | 0.47774030 |
| 115 | AKT3 | 0.47292835 |
| 116 | VRK2 | 0.47236638 |
| 117 | TESK2 | 0.46536970 |
| 118 | STK38L | 0.46248621 |
| 119 | MAP3K8 | 0.46132512 |
| 120 | BRSK1 | 0.46032165 |
| 121 | TEC | 0.44830321 |
| 122 | STK10 | 0.43118756 |
| 123 | CAMK2G | 0.42562894 |
| 124 | GRK7 | 0.42067756 |
| 125 | * SRC | 0.41368654 |
| 126 | RPS6KA2 | 0.41230631 |
| 127 | GRK5 | 0.38682810 |
| 128 | PDPK1 | 0.38074300 |
| 129 | CCNB1 | 0.37284922 |
| 130 | CAMK2D | 0.36170665 |
| 131 | MAP3K14 | 0.35492255 |
| 132 | AURKB | 0.32605166 |
| 133 | INSRR | 0.31861270 |
| 134 | MAPK12 | 0.31380161 |
| 135 | * ABL1 | 0.30744573 |
| 136 | BRSK2 | 0.30422544 |
| 137 | MAPKAPK2 | 0.29796988 |
| 138 | MTOR | 0.28714152 |
| 139 | PRPF4B | 0.28337938 |
| 140 | EIF2AK2 | 0.28172130 |
| 141 | EGFR | 0.26687525 |
| 142 | MAP3K1 | 0.23774633 |
| 143 | MAP3K5 | 0.22126779 |
| 144 | PRKCE | 0.21829589 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 3.25411899 |
| 2 | PPAR signaling pathway_Homo sapiens_hsa03320 | 3.24773990 |
| 3 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.88880604 |
| 4 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.67869394 |
| 5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.66874320 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.58742257 |
| 7 | * Focal adhesion_Homo sapiens_hsa04510 | 2.44048554 |
| 8 | Malaria_Homo sapiens_hsa05144 | 2.05534751 |
| 9 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.86007788 |
| 10 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.85140011 |
| 11 | Adherens junction_Homo sapiens_hsa04520 | 1.83188102 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.81341984 |
| 13 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.80964037 |
| 14 | * Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.79340354 |
| 15 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.77850716 |
| 16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.74995892 |
| 17 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.74746904 |
| 18 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.72045985 |
| 19 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.71116002 |
| 20 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.67551061 |
| 21 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.66000943 |
| 22 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.59210480 |
| 23 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.58066905 |
| 24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.56209807 |
| 25 | Amoebiasis_Homo sapiens_hsa05146 | 1.51223979 |
| 26 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.49982005 |
| 27 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.44733443 |
| 28 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.41022270 |
| 29 | Insulin resistance_Homo sapiens_hsa04931 | 1.40741386 |
| 30 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.27720086 |
| 31 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.25542249 |
| 32 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.22288830 |
| 33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.21249893 |
| 34 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.17166977 |
| 35 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.16855519 |
| 36 | Platelet activation_Homo sapiens_hsa04611 | 1.13803031 |
| 37 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.13148218 |
| 38 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.11981313 |
| 39 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.09654462 |
| 40 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.06268088 |
| 41 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.05910305 |
| 42 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.03787163 |
| 43 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.00677865 |
| 44 | Thyroid cancer_Homo sapiens_hsa05216 | 1.00102603 |
| 45 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.99965484 |
| 46 | Proteasome_Homo sapiens_hsa03050 | 0.98492921 |
| 47 | Tight junction_Homo sapiens_hsa04530 | 0.97490907 |
| 48 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.96661716 |
| 49 | Melanoma_Homo sapiens_hsa05218 | 0.96251690 |
| 50 | Galactose metabolism_Homo sapiens_hsa00052 | 0.95335609 |
| 51 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.95255724 |
| 52 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.94367927 |
| 53 | Pertussis_Homo sapiens_hsa05133 | 0.92421968 |
| 54 | Gap junction_Homo sapiens_hsa04540 | 0.92208313 |
| 55 | Phagosome_Homo sapiens_hsa04145 | 0.90820525 |
| 56 | Salmonella infection_Homo sapiens_hsa05132 | 0.90395854 |
| 57 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.89593575 |
| 58 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.88989076 |
| 59 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.88820145 |
| 60 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.88758261 |
| 61 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.86804038 |
| 62 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.85899653 |
| 63 | * Viral myocarditis_Homo sapiens_hsa05416 | 0.84963115 |
| 64 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.84845798 |
| 65 | Carbon metabolism_Homo sapiens_hsa01200 | 0.83059474 |
| 66 | Renin secretion_Homo sapiens_hsa04924 | 0.82092009 |
| 67 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.79850107 |
| 68 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.79608941 |
| 69 | Shigellosis_Homo sapiens_hsa05131 | 0.77527519 |
| 70 | Glioma_Homo sapiens_hsa05214 | 0.77362635 |
| 71 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.76254535 |
| 72 | Leishmaniasis_Homo sapiens_hsa05140 | 0.74124592 |
| 73 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.72690740 |
| 74 | Melanogenesis_Homo sapiens_hsa04916 | 0.72068639 |
| 75 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.70951019 |
| 76 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.68662508 |
| 77 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.67320094 |
| 78 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.66368985 |
| 79 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.65329365 |
| 80 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64957689 |
| 81 | Pathways in cancer_Homo sapiens_hsa05200 | 0.64532871 |
| 82 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.63600123 |
| 83 | Legionellosis_Homo sapiens_hsa05134 | 0.63245676 |
| 84 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.62390342 |
| 85 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.61823326 |
| 86 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.61597411 |
| 87 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.60927667 |
| 88 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.60541037 |
| 89 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.60290008 |
| 90 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.60187302 |
| 91 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.59875997 |
| 92 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.59845577 |
| 93 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.59607280 |
| 94 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.58980479 |
| 95 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.57909540 |
| 96 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.57213410 |
| 97 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.56290048 |
| 98 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.55028012 |
| 99 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.54900547 |
| 100 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.54863523 |
| 101 | * Endocytosis_Homo sapiens_hsa04144 | 0.52050014 |
| 102 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.50576802 |
| 103 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.50370555 |
| 104 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.50358799 |
| 105 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.49920476 |
| 106 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.49364905 |
| 107 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.48012781 |
| 108 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.46509230 |
| 109 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.46117057 |
| 110 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.45979975 |
| 111 | Lysosome_Homo sapiens_hsa04142 | 0.45860306 |
| 112 | Prostate cancer_Homo sapiens_hsa05215 | 0.45551788 |
| 113 | Bladder cancer_Homo sapiens_hsa05219 | 0.44223882 |
| 114 | Peroxisome_Homo sapiens_hsa04146 | 0.43763398 |
| 115 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.43604405 |
| 116 | Influenza A_Homo sapiens_hsa05164 | 0.43446969 |
| 117 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.43148392 |
| 118 | Hepatitis C_Homo sapiens_hsa05160 | 0.42894417 |
| 119 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.42646710 |
| 120 | Tuberculosis_Homo sapiens_hsa05152 | 0.42036741 |
| 121 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.41520361 |
| 122 | Endometrial cancer_Homo sapiens_hsa05213 | 0.41392276 |
| 123 | HTLV-I infection_Homo sapiens_hsa05166 | 0.41077356 |
| 124 | Sulfur relay system_Homo sapiens_hsa04122 | 0.40934902 |
| 125 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.40212843 |
| 126 | Cell cycle_Homo sapiens_hsa04110 | 0.40129700 |
| 127 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.39184148 |
| 128 | Apoptosis_Homo sapiens_hsa04210 | 0.39114695 |
| 129 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.39021099 |
| 130 | Axon guidance_Homo sapiens_hsa04360 | 0.38972587 |
| 131 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.38611040 |
| 132 | Other glycan degradation_Homo sapiens_hsa00511 | 0.37625949 |
| 133 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.37055937 |
| 134 | Colorectal cancer_Homo sapiens_hsa05210 | 0.36551819 |
| 135 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.34989809 |
| 136 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.34576040 |
| 137 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.33950556 |
| 138 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.33628295 |
| 139 | Prion diseases_Homo sapiens_hsa05020 | 0.32756319 |
| 140 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.32600148 |
| 141 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.32501083 |
| 142 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.32343095 |

